Effects of Dantrolene Therapy on Disease Phenotype in Dystrophin Deficient mdx Mice

PLoS Currents

Volumn , Issue NOV, 2013, Pages

  Quinn, James L ^a   Huynh, Tony ^b   Uaesoontrachoon, Kitipong ^a   Tatem, Kathleen ^a   Phadke, Aditi ^a   Van der Meulen, Jack H ^a   Yu, Qing ^a   Nagaraju, Kannaboyina ^a,c  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b CANBERRA HOSPITAL   (Australia)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CALPAIN; CATHEPSIN B; CREATINE KINASE; DANTROLENE; DYSTROPHIN; RNA; RYANODINE RECEPTOR 1; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DEATH; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFICACY; EXTENSOR DIGITORUM LONGUS MUSCLE; FATIGUE; FLUORESCENCE IMAGING; GENE EXPRESSION; GRIP STRENGTH; HISTOPATHOLOGY; MOUSE; MUSCLE CONTRACTION; MUSCLE INJURY; MUSCLE NECROSIS; MUSCLE STRENGTH; MUSCULAR DYSTROPHY; MYOSITIS; NONHUMAN; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; WESTERN BLOTTING;

EID: 84902503385     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.md.e246cf493a7edb1669f42fb735936b46     Document Type: Article

References (27)

1. Emery AE. Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord. 1991;1(1):19-29. PubMed PMID:1822774. 1822774.
2. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987 Dec 24;51(6):919-28. PubMed PMID:3319190. 3319190.
3. Allen DG, Gervasio OL, Yeung EW, Whitehead NP. Calcium and the damage pathways in muscular dystrophy. Can J Physiol Pharmacol. 2010 Feb;88(2):83-91. PubMed PMID:20237582. 20237582.
4. Turner PR, Westwood T, Regen CM, Steinhardt RA. Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature. 1988 Oct 20;335(6192):735-8. PubMed PMID:3173492. 3173492.
5. Morine KJ, Sleeper MM, Barton ER, Sweeney HL. Overexpression of SERCA1a in the mdx diaphragm reduces susceptibility to contraction-induced damage. Hum Gene Ther. 2010 Dec;21(12):1735-9. PubMed PMID:20540606. 20540606.
6. Andersson DC, Meli AC, Reiken S, Betzenhauser MJ, Umanskaya A, Shiomi T, D'Armiento J, Marks AR. Leaky ryanodine receptors in β-sarcoglycan deficient mice: a potential common defect in muscular dystrophy. Skelet Muscle. 2012 May 28;2(1):9. PubMed PMID:22640601. 22640601.
7. Gehrig SM, van der Poel C, Sayer TA, Schertzer JD, Henstridge DC, Church JE, Lamon S, Russell AP, Davies KE, Febbraio MA, Lynch GS. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature. 2012 Apr 4;484(7394):394-8. PubMed PMID:22495301. 22495301.
8. Fill M, Copello JA. Ryanodine receptor calcium release channels. Physiol Rev. 2002 Oct;82(4):893-922. PubMed PMID:12270947. 12270947.
9. Rossi AE, Dirksen RT. Sarcoplasmic reticulum: the dynamic calcium governor of muscle. Muscle Nerve. 2006 Jun;33(6):715-31. PubMed PMID:16477617. 16477617.
10. Gehrig SM, van der Poel C, Sayer TA, Schertzer JD, Henstridge DC, Church JE, Lamon S, Russell AP, Davies KE, Febbraio MA, Lynch GS. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature. 2012 Apr 4;484(7394):394-8. PubMed PMID:22495301. 22495301.
11. Bertorini TE, Palmieri GM, Griffin J, Igarashi M, Hinton A, Karas JG. Effect of dantrolene in Duchenne muscular dystrophy. Muscle Nerve. 1991 Jun;14(6):503-7. PubMed PMID:1852156. 1852156.
12. Paul-Pletzer K, Yamamoto T, Bhat MB, Ma J, Ikemoto N, Jimenez LS, Morimoto H, Williams PG, Parness J. Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor. J Biol Chem. 2002 Sep 20;277(38):34918-23. PubMed PMID:12167662. 12167662.
13. Spurney CF, Gordish-Dressman H, Guerron AD, Sali A, Pandey GS, Rawat R, Van Der Meulen JH, Cha HJ, Pistilli EE, Partridge TA, Hoffman EP, Nagaraju K. Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle Nerve. 2009 May;39(5):591-602. PubMed PMID:19260102. 19260102.
14. Rayavarapu S, Van der Meulen JH, Gordish-Dressman H, Hoffman EP, Nagaraju K, Knoblach SM. Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype. PLoS One. 2010 Sep 24;5(9):e12981. PubMed PMID:20886045. 20886045.
15. Baudy AR, Sali A, Jordan S, Kesari A, Johnston HK, Hoffman EP, Nagaraju K. Non-invasive optical imaging of muscle pathology in mdx mice using cathepsin caged near-infrared imaging. Mol Imaging Biol. 2011 Jun;13(3):462-70. PubMed PMID:20661652. 20661652.
16. Spurney CF, Cha HJ, Sali A, Pandey GS, Pistilli E, Guerron AD, Gordish-Dressman H, Hoffman EP, Nagaraju K. Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin beta-4 in the dystrophin deficient mouse. PLoS One. 2010 Jan 29;5(1):e8976. PubMed PMID:20126456. 20126456.
17. Rayavarapu S, Coley W, Cakir E, Jahnke V, Takeda S, Aoki Y, Grodish-Dressman H, Jaiswal JK, Hoffman EP, Brown KJ, Hathout Y, Nagaraju K. Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse. Mol Cell Proteomics. 2013 May;12(5):1061-73. PubMed PMID:23297347. 23297347.
18. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001 May 1;29(9):e45. PubMed PMID:11328886. 11328886.
19. Ellis KO, Bryant SH. Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium. Naunyn Schmiedebergs Arch Pharmacol. 1972;274(1):107-9. PubMed PMID:4262721. 4262721.
20. Bellinger AM, Reiken S, Carlson C, Mongillo M, Liu X, Rothman L, Matecki S, Lacampagne A, Marks AR. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med. 2009 Mar;15(3):325-30. PubMed PMID:19198614. 19198614.
21. Salimena MC, Lagrota-Candido J, Quírico-Santos T. Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice. Histochem Cell Biol. 2004 Nov;122(5):435-44. PubMed PMID:15452719. 15452719.
22. Grounds MD, Radley HG, Lynch GS, Nagaraju K, De Luca A. Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis. 2008 Jul;31(1):1-19. PubMed PMID:18499465. 18499465.
23. Bellinger AM, Reiken S, Carlson C, Mongillo M, Liu X, Rothman L, Matecki S, Lacampagne A, Marks AR. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med. 2009 Mar;15(3):325-30. PubMed PMID:19198614. 19198614.
24. Kendall GC, Mokhonova EI, Moran M, Sejbuk NE, Wang DW, Silva O, Wang RT, Martinez L, Lu QL, Damoiseaux R, Spencer MJ, Nelson SF, Miceli MC. Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy. Sci Transl Med. 2012 Dec 12;4(164):164ra160. PubMed PMID:23241744. 23241744.
25. Spencer MJ, Croall DE, Tidball JG. Calpains are activated in necrotic fibers from mdx dystrophic mice. J Biol Chem. 1995 May 5;270(18):10909-14. PubMed PMID:7738032. 7738032.
26. Quinlan JG, Johnson SR, Samaha FJ. Dantrolene normalizes serum creatine kinase in MDX mice. Muscle Nerve. 1990 Mar;13(3):268-9. PubMed PMID:2320049. 2320049.
27. Min JY, Meissner A, Feng X, Wang J, Malek S, Wang JF, Simon R, Morgan JP. Dantrolene: effects on abnormal intracellular Ca(2+) handling and inotropy in postinfarcted rat myocardium. Eur J Pharmacol. 2003 Jun 13;471(1):41-7. PubMed PMID:12809951. 12809951.